[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-why-johnson-johnson-stock-rose-50-last-year-and-could-set-new-highs-in-2026-FR":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":267,"suggestedPosts":346},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},95685,"Pourquoi l'action Johnson & Johnson a progressé de 50 % l'an dernier et pourrait atteindre de nouveaux sommets en 2026","2026-03-04T13:00:00","2026-03-04T05:35:00","\u003Cp>L'activité de médecine innovante de J&J a progressé de près de 15 % en 2025, hors STELARA, mais l'objectif moyen de Wall Street de 233,13 $ est inférieur au prix actuel, ce qui suggère que les analystes sous-évaluent le prochain cycle de croissance de l'entreprise.\u003C\u002Fp>\n","\n\u003Ch3 class=\"wp-block-heading\" id=\"h-key-stats-for-johnson-amp-johnson-stock\">Statistiques clés pour l'action Johnson &amp; Johnson\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Performance de la semaine dernière : \u003C\u002Fstrong>+2.4%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Fourchette de 52 semaines : \u003C\u002Fstrong> 141,5 $ à 251,7\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Cours actuel : \u003C\u002Fstrong> 246,8\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>La plupart des investisseurs ne savent jamais si une action est réellement sous-évaluée ou surévaluée. Les outils d'évaluation de TIKR, de qualité professionnelle, vous donnent une réponse claire et étayée par des données sur plus de 60 000 actions, et ce gratuitement.\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">\u003Cstrong>Que s'est-il passé ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>L'action Johnson &amp; Johnson\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=139677&amp;tid=2623227&amp;ref=tikrblog\">(JNJ\u003C\u002Fa>) se négocie à peine 2 % en dessous de son plus haut de 52 semaines (251,71 $), mais la retenue de l'action sous-estime une entreprise qui a dégagé 94,2 milliards de dollars de revenus en 2025 tout en construisant son pipeline le plus diversifié de l'histoire.\u003C\u002Fp>\n\n\n\n\u003Cp>Le 3 mars, la FDA a accordé la désignation Fast Track au nipocalimab pour le lupus érythémateux disséminé, sur la base des données de la phase 2b de JASMINE montrant une réduction de l'activité de la maladie chez 228 adultes, ajoutant ainsi une troisième indication approuvée ou déposée pour le même actif.\u003C\u002Fp>\n\n\n\n\u003Cp>En dessous de ce catalyseur, J&amp;J a affiché un BPA dilué ajusté de 2,46 $ au quatrième trimestre, en hausse de 20,6 % par rapport à l'année précédente, tandis que les marges de MedTech ont augmenté de 10,8 % à 17,4 % et que les marges de médecine innovante se sont améliorées de 32,5 % à 36,3 % au cours de ce même trimestre.\u003C\u002Fp>\n\n\n\n\u003Cp>Joaquin Duato, président-directeur général, a déclaré lors de la conférence téléphonique sur les résultats du quatrième trimestre que \"nous avons en ligne de mire une croissance à deux chiffres d'ici la fin de la décennie\", une affirmation désormais renforcée par le fait que TREMFYA a franchi la barre des 5 milliards de dollars de chiffre d'affaires en année pleine et vise 10 milliards de dollars au plus haut niveau.\u003C\u002Fp>\n\n\n\n\u003Cp>Avec 28 plateformes générant déjà 1 milliard de dollars ou plus par an, un objectif de flux de trésorerie disponible de 21 milliards de dollars pour 2026, l'expansion du nipocalimab dans le LED et le WAIHA, et la décision de la FDA concernant OTTAVA attendue au début de l'année prochaine, J&amp;J entre dans une fenêtre de composition pluriannuelle que son prix actuel n'a pas encore pris en compte.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Découvrez le moment exact où Wall Street revalorise un titre avant que le reste du marché ne le fasse - suivez les changements de notation des analystes en temps réel avec TIKR, et ce gratuitement →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-wall-street-s-take-on-jnj-stock\">\u003Cstrong>L'avis de Wall Street sur l'action JNJ\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>La désignation Fast Track de la FDA du 3 mars pour le nipocalimab dans le LED, qui s'ajoute à la demande WAIHA du 24 février, confirme une plateforme biologique multi-indications qui élargit directement les revenus adressables de J&amp;J bien au-delà des modèles consensuels actuels.\u003C\u002Fp>\n\n\n\n\u003Cp>Le chiffre d'affaires passe de 94,2 milliards de dollars en 2025 à une estimation de 100,6 milliards de dollars en 2026, tandis que le BPA normalisé grimpe de 10,79 à 11,53 dollars et que les marges EBITDA passent de 35,3 % à 36,7 %, ce qui confirme une accélération fondamentale constante plutôt qu'un rebond d'un an.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"842\" height=\"568\" data-public-id=\"images\u002Fimage-71_9568760d57\u002Fimage-71_9568760d57.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_842,h_568,c_scale\u002Ff_webp,q_auto\u002Fv1772600005\u002Fimages\u002Fimage-71_9568760d57\u002Fimage-71_9568760d57.png?_i=AA\" alt=\"johnson &amp; johnstock stock\" class=\"wp-post-95685 wp-image-95687\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772600005\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1772600005\u002Fimages\u002Fimage-71_9568760d57\u002Fimage-71_9568760d57.png?_i=AA 842w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_202,c_scale\u002Ff_webp,q_auto\u002Fv1772600005\u002Fimages\u002Fimage-71_9568760d57\u002Fimage-71_9568760d57.png?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_518,c_scale\u002Ff_webp,q_auto\u002Fv1772600005\u002Fimages\u002Fimage-71_9568760d57\u002Fimage-71_9568760d57.png?_i=AA 768w\" sizes=\"auto, (max-width: 842px) 100vw, 842px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Cible des analystes de la rue pour l'action JNJ \u003Cstrong>(\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>TIKR\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Wall Street compte 9 achats, 5 surperformances, 10 conservations et 1 sous-performance, avec un objectif de prix moyen de 233,13 $, ce qui implique une baisse de 5,5 % par rapport à 246,75 $, ce qui suggère que les analystes n'ont pas encore mis à niveau la force récente du titre et restent prudents à l'approche des catalyseurs à venir.\u003C\u002Fp>\n\n\n\n\u003Cp>La fourchette cible des analystes s'étend de 155 à 265 dollars, le plus bas reflétant l'escalade du litige sur le talc et la perturbation de la séparation de DePuy Synthes, tandis que le plus haut exige l'approbation du nipocalimab pour de multiples indications et le lancement d'OTTAVA aux États-Unis, ce qui stimulera les revenus de la robotique chirurgicale à partir de 2027.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-does-the-valuation-model-say\">\u003Cstrong>Que dit le modèle d'évaluation ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"832\" data-public-id=\"images\u002FJNJ_valuation_model-9\u002FJNJ_valuation_model-9.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1772600072\u002Fimages\u002FJNJ_valuation_model-9\u002FJNJ_valuation_model-9.webp?_i=AA\" alt=\"johnson &amp; johnstock stock\" class=\"wp-post-95685 wp-image-95688\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772600072\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1772600072\u002Fimages\u002FJNJ_valuation_model-9\u002FJNJ_valuation_model-9.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_244,c_scale\u002Ff_webp,q_auto\u002Fv1772600072\u002Fimages\u002FJNJ_valuation_model-9\u002FJNJ_valuation_model-9.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_624,c_scale\u002Ff_webp,q_auto\u002Fv1772600072\u002Fimages\u002FJNJ_valuation_model-9\u002FJNJ_valuation_model-9.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1248,c_scale\u002Ff_webp,q_auto\u002Fv1772600072\u002Fimages\u002FJNJ_valuation_model-9\u002FJNJ_valuation_model-9.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1663,c_scale\u002Ff_webp,q_auto\u002Fv1772600072\u002Fimages\u002FJNJ_valuation_model-9\u002FJNJ_valuation_model-9.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_975,c_scale\u002Ff_webp,q_auto\u002Fv1772600072\u002Fimages\u002FJNJ_valuation_model-9\u002FJNJ_valuation_model-9.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_1137,c_scale\u002Ff_webp,q_auto\u002Fv1772600072\u002Fimages\u002FJNJ_valuation_model-9\u002FJNJ_valuation_model-9.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Résultats du modèle d'évaluation de l'action JNJ \u003Cstrong>(\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=21127&amp;tid=2621295&amp;ref=tikrblog\">\u003Cstrong>TIKR\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Le modèle d'évaluation moyen évalue JNJ à 299,57 $ d'ici décembre 2030, ce qui implique un rendement total de 21,4 % et un TRI annualisé de 4,1 % par rapport aux niveaux actuels. Ce TRI modeste reflète le scepticisme du marché quant à la capacité de J&amp;J à dépasser sa trajectoire actuelle de croissance des revenus de 6 %.\u003C\u002Fp>\n\n\n\n\u003Cp>Le marché considère JNJ comme un conglomérat de soins de santé à croissance lente, mais si l'on exclut STELARA, Innovative Medicine a progressé de près de 15 % en 2025. J&amp;J a maintenant surmonté deux événements majeurs de perte d'exclusivité, REMICADE en 2018 et STELARA en 2025, un exploit qu'aucune autre société n'a égalé. Le directeur financier Joe Wolk a confirmé lors de la conférence de TD Cowen que le consensus reste \"un peu timide\" sur les estimations cardiovasculaires et chirurgicales jusqu'en 2028 et 2029.\u003C\u002Fp>\n\n\n\n\u003Cp>La vente de DePuy Synthes pour plus de 20 milliards de dollars ajouterait ~75 points de base de marge et de croissance au portefeuille restant, un événement de réévaluation que le prix actuel de 246,75 dollars ne reflète pas.\u003C\u002Fp>\n\n\n\n\u003Cp>La décision Daubert concernant le MDL sur le talc fait toujours l'objet d'un appel, et les coûts des litiges en cours ont déjà entraîné 0,9 milliard de dollars d'autres dépenses au quatrième trimestre, un passif que le marché continue d'ignorer par rapport aux résultats d'exploitation.\u003C\u002Fp>\n\n\n\n\u003Cp>L'appel à résultats du 14 avril pour le T1 2026 confirmera que la dynamique de la DCI de TREMFYA et l'expansion de CARVYKTI soutiennent une croissance à deux chiffres ou obligera les analystes à revoir à la baisse l'objectif moyen de 233,13 $.\u003C\u002Fp>\n\n\n\n\u003Cp>JNJ est assez bien valorisé aux prix actuels, mais devient un achat convaincant si la vente de DePuy se conclut à près de 20 milliards de dollars et si le nipocalimab obtient sa deuxième approbation avant la fin de l'année.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Les meilleures idées de Wall Street ne restent pas cachées longtemps. Avec TIKR, vous pouvez suivre gratuitement les révisions à la hausse des analystes, les résultats supérieurs aux attentes et les surprises en matière de chiffre d'affaires pour des milliers d'actions →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-should-you-invest-in-johnson-amp-johnson\">\u003Cstrong>Devriez-vous investir dans Johnson &amp; Johnson ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>La seule façon de le savoir est d'examiner les chiffres vous-même. TIKR vous donne un accès gratuit aux mêmes données financières de qualité institutionnelle que celles utilisées par les analystes professionnels pour répondre à cette question.\u003C\u002Fp>\n\n\n\n\u003Cp>En consultant l'action JNJ, vous verrez des années d'historique financier, les prévisions des analystes de Wall Street en matière de revenus et de bénéfices pour les trimestres à venir, l'évolution des multiples d'évaluation au fil du temps et la tendance à la hausse ou à la baisse des objectifs de prix.\u003C\u002Fp>\n\n\n\n\u003Cp>Vous pouvez créer une liste de surveillance gratuite pour suivre Johnson &amp; Johnson en même temps que toutes les autres actions qui vous intéressent. Aucune carte de crédit n'est nécessaire. Juste les données dont vous avez besoin pour décider par vous-même.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Accédez gratuitement à des outils professionnels pour analyser l'action JNJ sur TIKR →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n",848,"fr","\u002Fblog\u002Fwhy-johnson-johnson-stock-rose-50-last-year-and-could-set-new-highs-in-2026","why-johnson-johnson-stock-rose-50-last-year-and-could-set-new-highs-in-2026","images\u002FFEATURED-IMAGE-MAKER-398\u002FFEATURED-IMAGE-MAKER-398","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772600097\u002Fimages\u002FFEATURED-IMAGE-MAKER-398\u002FFEATURED-IMAGE-MAKER-398.png?_i=AA",{"altText":237,"imageCredit":238},"Why Johnson &amp; Johnson Stock Rose 50% Last Year and Could Set New Highs in 2026","TIKR",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Gian Estrada","giantikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"J&#038;J&#8217;s Innovative Medicine business grew nearly 15% in 2025 excluding STELARA, yet Wall Street&#8217;s mean target of $233.13 sits below the current price, suggesting analysts are underpricing the company&#8217;s next growth cycle.",{"title":260,"description":261,"twitterTitle":260,"twitterDescription":261,"author":240,"articlePublisher":262,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":263,"twitterData1":264,"ogTitle":260,"ogDescription":261,"ogUrl":232,"ogImage":235,"ogImageWidth":265,"ogImageHeight":266,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"Why Johnson & Johnson Stock Rose 50% Last Year and Could Set New Highs in 2026","J&J’s Innovative Medicine business grew nearly 15% in 2025 excluding STELARA, yet Wall Street’s mean target of $233.13 sits below the current price, suggesting analysts are underpricing the company’s next growth cycle.","TIKR.com","Temps de lecture estimé","7 minutes",1200,630,[268,285,302,317,332],{"id":255,"title":269,"date":270,"excerpt":271,"wordCount":272,"uri":273,"slug":274,"cloudinaryAssetId":275,"featuredImageOriginalUrl":276,"featuredImageMetadata":277,"author":278,"categories":282,"relatedPosts":284},"DoorDash a augmenté de 7% cette semaine. Voici à combien pourrait s'élever l'action d'ici 2028","2026-03-04 12:35:00","L'action DoorDash a augmenté d'environ 7 % cette semaine, les investisseurs ayant réagi à la publication de résultats solides et à l'intérêt continu des investisseurs institutionnels pour la société. Voici pourquoi l'expansion du réseau de livraison de DoorDash et l'amélioration de l'économie de marché pourraient favoriser une hausse à long terme.",698,"\u002Fblog\u002Fdoordash-rose-7-this-week-heres-how-much-the-stock-could-rise-by-2028","doordash-rose-7-this-week-heres-how-much-the-stock-could-rise-by-2028","images\u002F@Pop-Andreeas-Images-via-Canva\u002F@Pop-Andreeas-Images-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772613140\u002Fimages\u002F@Pop-Andreeas-Images-via-Canva\u002F@Pop-Andreeas-Images-via-Canva.png?_i=AA",{"altText":269},{"name":279,"slug":280,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":281},"Nikko Henson","nikkotikr",[],[283],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":286,"date":287,"excerpt":288,"wordCount":289,"uri":290,"slug":291,"cloudinaryAssetId":292,"featuredImageOriginalUrl":293,"featuredImageMetadata":294,"author":295,"categories":299,"relatedPosts":301},"L'action de Sea Limited chute de 16 % après les résultats du quatrième trimestre. Voici ce qui retient l'attention des investisseurs","2026-03-04 12:15:00","Voici pourquoi l'action de Sea Limited (SE) a chuté de 16,5 %, même après avoir annoncé un chiffre d'affaires d'environ 6,9 milliards de dollars au quatrième trimestre et des bénéfices en hausse.",741,"\u002Fblog\u002Fsea-limited-stock-slides-16-after-q4-results-heres-what-investors-are-focusing-on","sea-limited-stock-slides-16-after-q4-results-heres-what-investors-are-focusing-on","images\u002FSE-stock\u002FSE-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772625663\u002Fimages\u002FSE-stock\u002FSE-stock.png?_i=AA",{"altText":286},{"name":296,"slug":297,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":298},"Rexielyn Diaz","rexietikr",[],[300],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":303,"date":304,"excerpt":305,"wordCount":306,"uri":307,"slug":308,"cloudinaryAssetId":309,"featuredImageOriginalUrl":310,"featuredImageMetadata":311,"author":312,"categories":314,"relatedPosts":316},"Howmet Aerospace a augmenté de 21% au cours des 30 derniers jours. Voici où l'action pourrait aller en 2026","2026-03-04 12:05:00","L'action Howmet Aerospace a fait un bond d'environ 21% au cours du mois dernier, la forte demande dans le secteur de l'aérospatiale et les résultats solides ayant stimulé le sentiment des investisseurs. Voici pourquoi l'augmentation de la production d'avions et l'expansion de la demande de turbines pourraient continuer à soutenir les perspectives de l'action jusqu'en 2026.",707,"\u002Fblog\u002Fhowmet-aerospace-rose-21-in-the-past-month-heres-where-the-stock-could-go-in-2026","howmet-aerospace-rose-21-in-the-past-month-heres-where-the-stock-could-go-in-2026","images\u002F@Chirila-Sofias-Images-via-Canva-4\u002F@Chirila-Sofias-Images-via-Canva-4","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772610743\u002Fimages\u002F@Chirila-Sofias-Images-via-Canva-4\u002F@Chirila-Sofias-Images-via-Canva-4.png?_i=AA",{"altText":303},{"name":279,"slug":280,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":313},[],[315],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":318,"date":319,"excerpt":320,"wordCount":321,"uri":322,"slug":323,"cloudinaryAssetId":324,"featuredImageOriginalUrl":325,"featuredImageMetadata":326,"author":327,"categories":329,"relatedPosts":331},"L'action MongoDB plonge de 22% après de faibles perspectives de croissance dans le Cloud. Les analystes voient toujours une juste valeur de 443 $.","2026-03-04 12:00:00","Voici pourquoi l'action MongoDB (MDB) a plongé de 22 % après que les investisseurs ont mis l'accent sur une croissance plus faible de l'informatique dématérialisée et sur des perspectives mitigées.",599,"\u002Fblog\u002Fmongodb-stock-plunges-22-after-weak-cloud-growth-outlook-analysts-still-see-443-fair-value","mongodb-stock-plunges-22-after-weak-cloud-growth-outlook-analysts-still-see-443-fair-value","images\u002FMDB-stock-1\u002FMDB-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772624616\u002Fimages\u002FMDB-stock-1\u002FMDB-stock-1.png?_i=AA",{"altText":318},{"name":296,"slug":297,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":328},[],[330],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":333,"date":319,"excerpt":334,"wordCount":335,"uri":336,"slug":337,"cloudinaryAssetId":338,"featuredImageOriginalUrl":339,"featuredImageMetadata":340,"author":341,"categories":343,"relatedPosts":345},"L'action Zoetis : Pourquoi 12 produits phares du pipeline pourraient soutenir une hausse de 40 % ?","Zoetis vient d'acquérir l'activité génomique de Neogen, mais le véritable catalyseur arrivera plus tard, en 2026, lorsque CYTOPOINT à action prolongée demandera l'autorisation de mise sur le marché américain, une décision qui pourrait redéfinir l'ensemble de la situation concurrentielle de ZTS.",783,"\u002Fblog\u002Fzoetis-stock-why-12-pipeline-blockbusters-could-support-a-40-upside","zoetis-stock-why-12-pipeline-blockbusters-could-support-a-40-upside","images\u002FFEATURED-IMAGE-MAKER-396\u002FFEATURED-IMAGE-MAKER-396","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772595394\u002Fimages\u002FFEATURED-IMAGE-MAKER-396\u002FFEATURED-IMAGE-MAKER-396.png?_i=AA",{"altText":333},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":342},[],[344],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[347,368,383,398,416,428,443,457,472],{"id":255,"title":348,"date":349,"excerpt":350,"wordCount":351,"uri":352,"slug":353,"cloudinaryAssetId":354,"featuredImageOriginalUrl":355,"featuredImageMetadata":356,"author":358,"categories":362,"relatedPosts":367},"L'action Albemarle est en tête des pertes du S&P 500, le producteur de lithium chutant de 8 %.","2026-03-04 10:58:00","Les actions d'Albemarle chutent de 8 % en raison de la chute de 13 % des prix du lithium en Chine. La faiblesse des ventes de VE de BYD et les tensions au Moyen-Orient assombrissent les perspectives de la demande pour le producteur.",596,"\u002Fblog\u002Falbemarle-nyse-stock-leads-sp-500-losses-as-lithium-producer-sinks-8","albemarle-nyse-stock-leads-sp-500-losses-as-lithium-producer-sinks-8","images\u002FALB-stock\u002FALB-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772620530\u002Fimages\u002FALB-stock\u002FALB-stock.png?_i=AA",{"altText":357},"L'action Albemarle est en tête des pertes du S&amp;P 500, le producteur de lithium chutant de 8 %.",{"name":359,"slug":360,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":361},"Aditya Raghunath","adityatikr",[],[363],{"name":364,"slug":365,"uri":366,"description":243,"postsCount":255},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":369,"date":370,"excerpt":371,"wordCount":372,"uri":373,"slug":374,"cloudinaryAssetId":375,"featuredImageOriginalUrl":376,"featuredImageMetadata":377,"author":378,"categories":380,"relatedPosts":382},"Barclays ramène la note de l'action Blue Owl à \"Equal Weight\" alors que la chute du cours de l'action se poursuit","2026-03-03 11:59:00","Barclays abaisse la note de Blue Owl Capital en raison d'un fort ralentissement des entrées de capitaux dans les BDC non cotées et d'une forte augmentation des rachats. L'action a baissé de 50 % au cours de l'année écoulée en raison des craintes liées au crédit.",775,"\u002Fblog\u002Fbarclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","barclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","images\u002FOWL-stock-1\u002FOWL-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772533744\u002Fimages\u002FOWL-stock-1\u002FOWL-stock-1.png?_i=AA",{"altText":369},{"name":359,"slug":360,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":379},[],[381],{"name":364,"slug":365,"uri":366,"description":243,"postsCount":255},[],{"id":255,"title":384,"date":385,"excerpt":386,"wordCount":387,"uri":388,"slug":389,"cloudinaryAssetId":390,"featuredImageOriginalUrl":391,"featuredImageMetadata":392,"author":393,"categories":395,"relatedPosts":397},"L'action Novo Nordisk atteint son plus bas niveau en 52 semaines, Goldman Sachs la rétrograde à \"neutre\".","2026-03-03 10:55:00","L'action Block a augmenté de plus de 20 % après que la société fintech a annoncé qu'elle allait licencier plus de 4 000 employés, soit environ la moitié de ses effectifs.",655,"\u002Fblog\u002Fnovo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","novo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","images\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772532602\u002Fimages\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1.png?_i=AA",{"altText":384},{"name":359,"slug":360,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":394},[],[396],{"name":364,"slug":365,"uri":366,"description":243,"postsCount":255},[],{"id":255,"title":399,"date":400,"excerpt":401,"wordCount":402,"uri":403,"slug":404,"cloudinaryAssetId":405,"featuredImageOriginalUrl":406,"featuredImageMetadata":407,"author":408,"categories":410,"relatedPosts":415},"En baisse de 9 % par rapport à son plus haut niveau historique, l'action Stryker peut-elle offrir de nouveaux rendements en 2026 ?","2026-03-04 10:55:00","La forte dynamique du Mako et la croissance robuste du MedSurg sont à l'origine des perspectives de Stryker. L'action pourrait atteindre 503 $ d'ici 2028, ce qui représente une hausse de 30 % par rapport aux niveaux actuels.",1262,"\u002Fblog\u002Fdown-9-from-all-time-high-can-stryker-nyse-stock-deliver-further-returns-in-2026","down-9-from-all-time-high-can-stryker-nyse-stock-deliver-further-returns-in-2026","images\u002FSYK-stock\u002FSYK-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772517855\u002Fimages\u002FSYK-stock\u002FSYK-stock.png?_i=AA",{"altText":399},{"name":359,"slug":360,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":409},[],[411],{"name":412,"slug":413,"uri":414,"description":243,"postsCount":255},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":417,"date":400,"excerpt":418,"wordCount":402,"uri":419,"slug":420,"cloudinaryAssetId":-1,"featuredImageOriginalUrl":421,"featuredImageMetadata":422,"author":423,"categories":425,"relatedPosts":427},"En hausse de 54 % au cours des 12 derniers mois, l'action Analog Devices peut-elle continuer sur sa lancée en 2026 ?","L'action d'Analog Devices a bondi de 56 % en 12 mois grâce à la demande d'infrastructures d'IA. Cette dynamique peut-elle se poursuivre ? Nous analysons l'objectif de cours de 422 $ d'ADI et son potentiel de hausse de 20 %.","\u002Fblog\u002Fup-56-in-last-12-months-can-analog-devices-nyse-adi-stock-continue-its-strong-run-in-2026","up-56-in-last-12-months-can-analog-devices-nyse-adi-stock-continue-its-strong-run-in-2026","https:\u002F\u002Ftikr1.wpengine.com\u002Fwp-content\u002Fuploads\u002F2026\u002F03\u002FADI-stock-600x400.png",{"altText":417},{"name":359,"slug":360,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":424},[],[426],{"name":412,"slug":413,"uri":414,"description":243,"postsCount":255},[],{"id":255,"title":429,"date":430,"excerpt":431,"wordCount":432,"uri":433,"slug":434,"cloudinaryAssetId":435,"featuredImageOriginalUrl":436,"featuredImageMetadata":437,"author":438,"categories":440,"relatedPosts":442},"En baisse de 25 % par rapport à son plus haut niveau historique, l'action Capital One peut-elle offrir de meilleurs rendements en 2026 ?","2026-03-03 11:25:00","L'action Capital One pourrait générer des rendements de 30 % d'ici 2028, l'intégration de Discover et l'acquisition de Brex débloquant la croissance du réseau de paiements et l'expansion des services bancaires aux entreprises.",1309,"\u002Fblog\u002Fdown-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","down-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","images\u002FCOF-stock\u002FCOF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772516734\u002Fimages\u002FCOF-stock\u002FCOF-stock.png?_i=AA",{"altText":429},{"name":359,"slug":360,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":439},[],[441],{"name":412,"slug":413,"uri":414,"description":243,"postsCount":255},[],{"id":255,"title":444,"date":385,"excerpt":445,"wordCount":446,"uri":447,"slug":448,"cloudinaryAssetId":449,"featuredImageOriginalUrl":450,"featuredImageMetadata":451,"author":452,"categories":454,"relatedPosts":456},"En hausse de 20 % au cours des 12 derniers mois, l'action Synchrony Financial peut-elle évoluer à la hausse en 2026 ?","En hausse de 20% sur 12 mois, Synchrony Financial est prometteur avec la croissance du partenariat avec Walmart. Notre modèle prévoit une hausse de 27% à 87 $ d'ici décembre 2028. Analyse à l'intérieur.",1261,"\u002Fblog\u002Fup-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","up-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","images\u002FSYF-stock\u002FSYF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772512295\u002Fimages\u002FSYF-stock\u002FSYF-stock.png?_i=AA",{"altText":444},{"name":359,"slug":360,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":453},[],[455],{"name":412,"slug":413,"uri":414,"description":243,"postsCount":255},[],{"id":255,"title":458,"date":459,"excerpt":460,"wordCount":461,"uri":462,"slug":463,"cloudinaryAssetId":464,"featuredImageOriginalUrl":465,"featuredImageMetadata":466,"author":467,"categories":469,"relatedPosts":471},"En hausse de 42 % en 3 ans, l'action de Raymond James Financial peut-elle continuer à progresser ?","2026-03-03 09:55:00","L'action Raymond James a baissé de 10 % en 12 mois. Un fort recrutement, 31 milliards de dollars de nouveaux actifs nets signalent une reprise. Notre modèle prévoit une hausse de 21 % pour atteindre 185 $ d'ici septembre 2028.",1234,"\u002Fblog\u002Fup-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","up-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","images\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772467602\u002Fimages\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878.png?_i=AA",{"altText":458},{"name":359,"slug":360,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":468},[],[470],{"name":412,"slug":413,"uri":414,"description":243,"postsCount":255},[],{"id":255,"title":473,"date":400,"excerpt":474,"wordCount":475,"uri":476,"slug":477,"cloudinaryAssetId":478,"featuredImageOriginalUrl":479,"featuredImageMetadata":480,"author":481,"categories":483,"relatedPosts":488},"Pourquoi l'action d'AeroVironment a chuté de plus de 20 % cette semaine","AeroVironment plonge de 19 % après que l'armée de l'espace a rouvert l'appel d'offres pour un contrat SCAR de 1,4 milliard de dollars. Raymond James rétrograde l'action de \"strong buy\" à \"underperform\".",799,"\u002Fblog\u002Fwhy-aerovironment-avav-stock-tanked-over-20-this-week","why-aerovironment-avav-stock-tanked-over-20-this-week","images\u002FAVAV-stock_955099f985\u002FAVAV-stock_955099f985","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772536085\u002Fimages\u002FAVAV-stock_955099f985\u002FAVAV-stock_955099f985.png?_i=AA",{"altText":473},{"name":359,"slug":360,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":482},[],[484],{"name":485,"slug":486,"uri":487,"description":243,"postsCount":255},"Mises à Jour des Résultats","earnings-updates","\u002Fblog\u002Fcategory\u002Fearnings-updates",[]]